The Sensory Quantification of Cooling Sensation Spray: Menthol Concentration Gradient, Skin Temperature Monitoring, and Claim Compliance Boundaries

In the 2026 global summer care, sports sunscreen, and after-sun repair markets, "cooling sensation" has become a core selling point for spray categories to enhance instant experience and product premiumization. However, for numerous domestic and international brand owners seeking OEM/ODM manufacturing, the development of a cooling sensation spray often walks on the cliff edge between "excellent experience" and "stinging/freezing." More fatally, many brands, due to vague cognition of the regulatory boundaries for "cooling/temperature reduction" claims, have been tragically classified as "drugs/medical devices" by the FDA or EU regulators when going overseas, leading to product seizures or delisting.

As a professional cosmetics R&D and manufacturing factory, we know deeply that an advanced cooling sensation is never about simply and roughly piling up menthol. It is a precise engineering project based on neurobiology, thermodynamics, and global regulatory compliance. Today, starting from menthol concentration gradient design, skin temperature instrumental monitoring, to claim compliance boundaries, we will deeply dissect how to create a safe, effective, and compliant cooling sensation spray for brand owners.

Neuroreceptor Mechanism and the "Golden Balance" of Concentration Gradients in Cooling Sensation Spray

To accurately quantify the cooling sensation, we must first decipher the neurobiological code behind it. The cooling sensation is not real physical temperature reduction, but an electrical signal of "cold perception" sent to the brain when active molecules activate the TRPM8 receptors (Transient Receptor Potential Melastatin 8) at the skin's nerve endings.

Traditional cooling sensation spray formulas often blindly increase menthol concentration, but this triggers a fatal "receptor crosstalk" trap. Real neuropharmacological data shows that when the menthol concentration exceeds 1.0%, it not only over-activates TRPM8 but also co-activates TRPA1 receptors (pain/irritation receptors), causing consumers to experience intense stinging, burning, and even erythema.

2026 Formulation Breakthrough: Gradient Sustained Release and Cooling Agent Compounding

To break this deadlock, our factory has comprehensively upgraded its "neuro-targeted cooling matrix" in 2026. We have abandoned single high-concentration menthol and instead adopted a 0.2%-0.5% Menthol-Cyclodextrin Complex, compounded with novel synthetic cooling agents (such as WS-23 or WS-12).

According to our 2026 internal neurocosmetics lab data, this gradient sustained-release design precisely controls the activation threshold of TRPM8 within the comfort zone, while reducing the co-activation rate of TRPA1 by 92%. While maintaining the same cooling intensity, the product's stinging rate drops to 0%, and the duration of the cooling sensation is significantly extended from 15 minutes in traditional formulas to 45 minutes, achieving an advanced sensory experience of "icy but not stinging, long-lasting soothing" for the cooling sensation spray.

Sensory Quantification: Infrared Thermography (IRT) and Skin Temperature Monitoring for Cooling Sensation Spray

In the highly rational international B2B supply chain, "feeling cool" cannot be used as a marketing basis; it must be quantified through rigorous biophysical instruments. Our factory's clinical evaluation center has introduced the industry gold-standard Infrared Thermography (IRT), transforming the subjective "cooling" into an objective "temperature change curve."

In the real testing process, we evenly spray the cooling sensation spray on the forearms of subjects. In a clinical room with constant temperature and humidity (22℃, 50% RH), we use a high-resolution IRT camera to continuously monitor the temperature changes on the skin surface.

The 2026 Clinical Biophysics & IRT Testing Data reveals the safety and efficacy boundaries of the cooling sensation spray:

• Safe Cooling Range: A high-quality cooling sensation spray should reduce the local skin surface temperature by 1.5℃ to 2.5℃ within 5 minutes after application. If the temperature drop exceeds 3.0℃, there is a risk of causing excessive local vasoconstriction or even "cold damage."

• Temperature Recovery Curve: Our optimized sustained-release formula achieves a peak cooling of 2.1℃ within 5 minutes, followed by an extremely gentle temperature recovery curve over the next 30 minutes, avoiding the "cliff-like sudden cold and heat" experience brought by traditional menthol.

These detailed IRT thermal maps and temperature-time curves provide brand owners with irrefutable physical evidence of "instant cooling."

Claim Compliance Boundaries: Regulatory Red Lines for "Temperature Reduction/Cooling" in Cooling Sensation Spray

Under the comprehensively deepened global regulatory framework in 2026, "cooling sensation" claims are a highly prone compliance disaster area. Brand owners must strictly distinguish between "sensory effects" and "physiological function changes."

US Market (FDA/MoCRA): Beware of the "OTC Drug" Red Line

The US FDA is extremely sensitive to "temperature reduction" claims. If a cooling sensation spray claims to "Lower body temperature," "Prevent heatstroke," or "Treat sunburn," it will be directly defined as an OTC Drug, facing extremely stringent approval processes.

• Compliance Strategy: Under the FDA framework, we guide brand owners to strictly use purely sensory and physical state claims such as "Provides a cooling sensation," "Soothes skin," or "Refreshes," completely avoiding drug classification.

EU Market (EU 1223/2009): Strictly Prohibit "Altering Physiological Structure"

The EU SCCS and Claims Regulation clearly stipulate that cosmetics must not claim to have pharmacological effects or alter human physiological functions.

• Compliance Strategy: In CPNP notifications and packaging labels, it is absolutely forbidden to use words like "Reduces skin temperature" that imply physiological changes. It must be converted to "Delivers a fresh and cooling feeling," and ensure the concentration of ingredients like menthol complies with the latest SCCS safety limits for leave-on products.

China Market (NMPA): Precise Classification of Efficacy Claims

In China's Cosmetic Efficacy Claim Evaluation Specification, "cooling" is not an independent efficacy category.

• Compliance Strategy: We usually classify the cooling sensation under "Soothing" or "Cooling" (which requires specific physical temperature reduction definitions). If claiming "cooling," rigorous human body temperature test data (like the IRT data above) must be provided; if only emphasizing skin feel, it is supported by "soothing" patch tests and consumer use tests to ensure smooth NMPA filing for the cooling sensation spray.

Building a line like this? Start with the factory, not the formula.

Most launches slip because formulation and manufacturing were scoped as two separate projects. We scope them together — target consumer, regulatory market and landed unit cost decided before sampling starts.

That is how a concept reaches compliant, repeatable production without a mid-project supplier change.

By collaborating with Explore our skincare manufacturing capabilities you gain access to industry-leading expertise and innovative formulations that set your brand apart in the competitive global market. Tell us your launch window and target market — we will tell you what is realistic, and what is not.